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Sjogren-Larsson syndrome (SLS) is an autosomal re-
cessive disorder characterized by congenital ichthy-
osis, mental retardation, and spastic diplegia or tet-
raplegia. Patients with SLS have deficient activity of 
fatty aldehyde dehydrogenase (FALDH), an enzyme 
involved in long-chain fatty alcohol oxidation. The 
eDNA encoding FALDH has recently been cloned 
and several different mutations have been found in 
SLS patients. We have now identified a point muta-
tion (C943 ---7 T) in 7 of 19 kindreds of European 
descent, accounting for 24% of the SLS alleles. The 
C943T 1nutation was only found in patients of north-
ern European ancestry fro1n Sweden, the Nether-
lands, Gennany, and Belgiun1. Haplotype analysis 
suggested that the patients carrying the C943T allele 
S jogren-Larsson syndrom e (SLS) is an autosomal reces-s· ive disorder chat·actedzed by the presence of co. ngenital ich thyosis, m ental t·etardation , and spastic diplegia or tetraplegia (Sj ogren and La rsson, 1957; J agell cl a/ , 1981; R.izzo , 1993). The ichthyos is is usuall y presen t at birth 
and brin gs the patien t to m edical attention Qagell and Liden , 1982; 
Goldsm.itb er nl, 1971 ) . The onset of the nemologic sympto m s. 
howe ver, w ithin the first 3 y o f life typi cally prompts the dia gnosis 
of SLS . M ental retardation and spasti city becom e apparent as a 
delay in achi ev in g m otor and verbal milestones. Additional clinical 
features tha t are often presen t include g listening white do ts on the 
retina , seizures, sho rt stature, and speech defects. 
SLS was first described in a coho rt of inbred patients fi·om 
north ern Swede n (Sjogren and La rsson , 1957) , but other pa tients 
have now been identifi ed worldw ide (Theile, 1974). T he incide nce 
of thi s di sease is unknown , but the preva lence of SLS iJl Sweden is 
esti m ated to be 0.4 per 100,000 Qagell et a/, 1981 ). The SLS gene 
has been mapped to chxomosom e 17p11 .2 by linkage analysis of 
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were distantly related. All four Swedish patients were 
homozygous for C943T, indicating that this mutation 
is probably the major cause of SLS in the inbred 
Swedish families. The mutation leads to the substitu-
tion of serine for the highly conserved proline 315 in 
the FALDH protein, and expression studies confirm 
that it destroys enzymatic activity. The mutation was 
readily detected with an MrrU restriction enzyme 
digestion test. The finding that C943T is a common 
SLS Inutation in northern European and Swedish 
patients affords a rapid simple method for diagnosing 
SLS by screening patients for this mutation with 
DNA-based methods. K ey wm·ds: iclrtlryosislmeutal retar-
datiorrlspasticitylaldelryde delrJ'drogerrase. J Irrvest Der•matol 
109:79-83, 1997 
Swedish (Pigg et a/, 1994) and non-Swedish fa mil.ies (Koget·s et a/, 
1995; Lacour el a/, 1996). 
Patients with SLS h ave deficien t activi ty of fatty aldehyde 
dehydrogenase (FALDH; R..izzo and Craft, 199 1 ), an enzym e th at 
is necessary for the oxidation of fatty alcohol to f.• tty acid through 
its in volvem ent as a component of the fatty alcohol:NAD + ox:i-
do t·edu ctase enzym e compl ex (Rizzo 1'1 a/, 1988, 1989). Aft"ected 
patients have impaired h1tty alcoho l ox idation and consequently 
accumula te lo ng- chain alcoho l in their tissues (Rizzo er a/, 1989; 
R.izzo. 1993). Although the pathogenesis is yet unclear, fatty 
alcoho l storage is tho ught to be t·esponsible for the symptoms of the 
disease (Rizzo . 1993 ). Enzymatic testin g is useful for diagnosing 
SLS patien ts. detecting ca rriers (Kelson el a/, 1992), and performin g 
prenatal diagnosis (Rizzo ct a/, 1994) . 
T he eDNA encoding FALDH has recentl y been cloned and 
m apped to the SLS locus (De Laurenz i cl a/, 1996). T he FALD H 
gene consists of 10 exons and spans abo u t 30 kb (Chang and 
Yoshida, 1997; Rogers ct a/ , 1997). T hree unre lated SLS patients 
we re found to have four different mutatio ns in the FALDH gene, 
including two small deletio ns. n compl ex deletion / in sertio n . and a 
point mutation (De Laurenzi ct a/, 1996). When ana lyzing add i-
tio nal patients wh o were though t to be geneticall y unrelated, w e 
enco unte red an iden tica l poinr mutation (C943~ T) in a gro up of 
probnnds from northern Europe and Sweden . We now report that 
this mu tati on is a commo n ca use of SLS in patien ts fi·om this 
geographic at·ea. T he fi ndin g of a similar haplotype in patients 
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carrying this mutation strongly suggests that they are distantly 
re lated. 
MATEIUALS AND METHODS 
Patients All SLS patients were confirmed to have defi ciency of FALDH 
and /or fatty alcohol:NAD+ oxidoreductase by m easuring their enzyme 
activities in cul tured skin fibroblasts as described (Rizzo and Craft, 1991; 
Rizzo el a/, 1994) . These patients showed evidence of ichthyosis, mental 
retardation, and spasticity on physical examination . With the exception of 
the four Swedish patients, none of the other probands were known to be 
geneti ca ll y related. 
Mutation Analysis Mutation anal ysis was initially performed on two 
probands, one of Dutch ancestry and the other from Sweden, by directly 
sequencing the FALDH eDNA amplifwd from fibroblast RNA by reverse 
transcJ·iption-coupled polymerase chain reaction (PCR) as described (De 
Laurenzi et al, 1996). All eDNA fi·agments were sequenced in both 
directions by using the fino! DNA sequencing kit (Promega Corp., Madi-
son, WI) with the same primers used to generate the fi:agments. Additional 
probands from apparently unreh1ted f;Jm iJi es were screened for tl1.e C943T 
mutation by amplifying a 309-bp DNA fragment from exon 7 using 
genomic DNA derived from buccal brushings (Richards et a/, 1993) or 
cultured skin ~ibroblasts . The o ligonucleotide primers used to amplify this 
DNA fragment by PCR consisted of an intronic sense primer (5' -GCA-
CAGTTCATCCACGTGCTCAG-3 ') and an exon.ic anti-sense primer 
(5' -GCGAAAATACATAAAGAGCCAGAGGCTTTTCACG-3 '). After an 
initia l denaturation at 95°C for 5 min, 35 cycles of the following thermo-
cycling conditio ns were performed: 94 °C for 0.5 min, 60°C for 1 min , and 
72 °C for 0.5 min. A final extension at 72°C was for 10 mi11 . 
To detect the C943T mutation, the PCR products (0.5 J.tg) were digested 
overnigh t at 37"C with 5 1111its of Mnll (New England Biolabs, Beverly, 
MA) in tl1e presence of bovine serum albumin according to the manufac-
turer's instructions. Digestion products were electrophoresed in 3°/., agarose 
gels, sta ined with ctl1idium bromide, and photographed. 
Baculovirus Expression of Noc-mal and Mutant FALDH The full-
length eDNA coding sequence for FALDH was generated by digesting two 
overlapping eDNA clones (De L1urcnzi ct a/, 1996) containi11g a shared 
Hi11dlll restriction site and subsequently ligating the restriction fragments. 
The complete coding portion of the resulting FALD H eDNA was se-
quenced and found to encode the normal FALDH protein. 
For baculovirus expression, the coding region of the FALDH eDNA was 
cloned into the pAcJ-ILT-B transfer vector (Pharmigen, San Diego, CA) 
between a N co l restriction site and a Noti restriction site. This vector was 
designated pAcHLT-13/FALDHwt and encodes a fusion protein consisting 
of a 45-amino acid peptide with a polyhistidine tag attached to the amino 
te rminus of FALDH. Express io n of the recombinant FALDH is under the 
contro l of cia: strong baculovirus polyhed rin promoter. Site-directed mu-
tageuesi~ was performed o n pAcHLT-B/FALDI-l-wt by using the Trans-
fo rmer site-directed mutagenesis kit (Cion tech, Palo Alto, CA) according to 
the protocol provided by the manufacturer. The primers used were 
5 ' -CGCTACATAGCCTCAACAGTCCTTACCG-3' , which introduced 
the C943T mutation and destroyed a nearby Sea l site, and 5' -GACTTG-
GTTGAGTATTCACCAGTCACAG-3 ' , which destroyed a Seal site in the 
pAcHL T -B transfer vector. The resu lting mutant vector is designated 
pAcl-lLT-B/FALDH-C943T. 
T he normal FALDH vector and the mutated vector (2 J.tg) were 
individually cotransfectcd into Sf9 cell s with the linearized baculovirus 
DNA (0.5 J.tg) (BaculoGold, Pharmigcn) by calcium phosphate precipitation 
accord ing to the manufacturer' s protocol. After 4 h the transfected Sfl) cell s 
were cultured in Grace's insect n1cdiun1 containing 1 QlX, fetal bovh1c seru.-n 
without ch anging the medium . T he cell s showing the infected phenotype 
were harvested after 5 d, and tbe culture supernatant was co llected and used 
for further infections. Three rounds of amplification were done to obtain a 
high- titer vira l stock. T he protei n expression was checked by gel electro-
phoresis and optimized at a hig h multiplicity of infection . 
For measuring the FALDH activity in baculovi rus-infected cells three 
25-cm2 Aasks. each containing 3 X 106 cells, were infected with each virus 
stock. After 72 h the cells were scraped, pelletcd, and frozen. Cell pe llets 
were the n resuspended in 1 ml of 25 mM Tris(hydroxymcthyl)aminometh-
an e hydrochloride, pH 8, and 0.25 M sucrose and lysed by sonication . 
Triton X-100 was added at a final concentration ofO.l %. FALDH activity 
was measured in cell sonicates using octadecanal as substrate according to 
R.i zzo and Craft (199'1) with minor modification (R.izzo er nl, 1994). 
Immunostaining of Expressed Recombinant FALDH Protein Rat 
liver microsomal aldehyde dehydrogenase, which shows 84'X• amino acid 
identity with human FALDH, was purified (Kelson el a/, in press) and used 
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Figure 1. Sequencing gel showing the C943T mutation in patient 
2A (sec Table I) based on sequencing FALDH mRNA amplified by 
reverse transcription-coupled PCR. Patient 3 (Table I) showed tbe 
same sequencing gel pattern (sec text). This mutation results in substitution 
of serine for proline 315. 
as an antigen to raise a rabbit antisen1n1. Baculovirus-c"''Pressed proteins 
were separated by sodium dodecyl sulfate-polyacrylamide gel electrophore-
sis, blotted onto nitrocel.lulose membranes, and irmnunostained with a 1:100 
dilution of the rabbit anti-rat mkrosomal aldehyde dehydrogenase accord-
ing to standard procedures. Bound a11tibody was detected using tl1 e 
SuperSignal chemiluminescent detection kit (Pierce Chemical Co, Rock-
ford, IL) . 
Haplotype Analysis Patients who ca rried the C943T mutation were 
genotyped for Dl7S805, D17S689, D17S842, and a FALDH microsatellite 
repeat (see below) as described by Rogers et a/ (1995). Centre d'Etudes du 
Polymorph.isme Humaine reference individual 134702 was also genotyped 
for D17S805 and D17S842 so that resu lts could be directly compared with 
those reported by Pigg el a/ (1994). 
We mapped a previously reported microsatellite repeat (Gcnlla11k acces-
sion number Z67319) to intron 8 of the FALDH gene. Oligonucleotide 
primers used to amplify this FALDH microsatel lite repeat were (sense) 
5 ' -TGTICACTTCGTTGA TTTTGTT A TCCTGCC-3' and (anti-sense) 
5'- CCTTCTGTCCCTGGTATTCCGAACCT-3'. Amplification oftl1e re-
peat in 42 unrelated Caucasian individuals revea led 10 alleles and polymor-
phism information content of 0.53. 
RESULTS 
Identification of the C943T Mutatio n We performed muta-
tion a11alysis on two apparently unrelated SLS probands, one of 
Swedish ancestry and the other of Dutch descent. The entire coding 
portion of the FALDH gene was sequenced by using fibroblast 
mRNA amplified by reverse transcription-coupled PCR. Both SLS 
patients were found to carry a mutation (C943 _.,. T) that leads to 
replacement of proline 315 with serine (Fig 1). This proline 315 is 
highly conserved across all aJdehyde dehydrogenases isozymes 
(Hempel et al, 1993). No other mutations were detected in the 
eDNA. The C943T mutation creates a new Mnll restriction site 
(Fig 2). When a 309-bp fragment of exon 7 was amplified by PCR 
from genomk DNA and digested with A1u/I, the Swedish patient 
was found to be homozygous for C943T, whereas the Dutch 
patient and her affected sister were heterozygous (Fig 2). The 
father of the Dutch patients was found to carry the C943T mutation 
in a heterozygous state, and the mother showed the normal 
digestion pattern. Thus, the Dutch patients were compound het-
erozygotes for C943T and another, as yet unidentified mutation, 
carried by the mother that was not detected in the proband by 
sequencing the coding portion of the FALDH mRNA. 
Expression of Mutant FALDH in Baculovirus-infected Cells 
The mean residual FALDH activity in cultured skin fibroblasts from 
five SLS patients who were homozygous for the C943T mutation 
(see below) was reduced to 7% of the mean activity in normal 
controls, and obligate heterozygotes showed an intermediate en-
zyme reduction (58"1<, of normal, n = 4) . Since approximately 6% of 
the activity rneasured in normal cells is probably due to other 
aldehyde dehydrogenase enzymes that cross-react with the sub-
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Figure 2. Mull digestion of the amplified 309-bp genomic DNA 
fragment from exon 7 containing the C943T mutation. (Uppe1) The 
normal allele is digested to produce fragments that are 199 bp, 50 bp, 4 7 bp , 
'llld 13 bp. T he mutant allele has an additional resrriction site that cleaves 
the normal 199-bp fragment into 118-bp and 81-bp fragments. (Lowe1) .An 
M 11ll digestion analysis of a Dutch family (proband 3 in Table I) demon-
strating that the C943T mutation is present in a heterozygous state in both 
affected siblings (solid symbols, ln11es 4,5) and their father (ln11e 2) . The 
mother (la11e 3) does not carry the C943T mutation. A Swedish patient (S, 
ln11e 6) is homozygous for C943T. Normal controls (N) arc in la11 e.~ 1 and 7. 
strate in the FALDH assay (Rizzo and Craft, 1991; De Lamenzi et 
a/, 1996), th ese results suggest that the C943T mutation causes a 
drastic reduction in FALDH activity. 
To unambiguously dem o nstrate that C943T is responsible for 
loss of FALDH activity, we expressed the mutant FALDH in a 
baculoviru s expression system. R ecombinant baculovirus strains 
were produced that contained FALDH eDNA that directed the 
synthesis of either no rmal FALDH en zyme (pAcHLT-B/FALDI-1-
wt) or mutant en zym e with serin e substituted for proline 315 
(pAcHLT-B/FALDH-C943T). Both proteins were synthesized 
with a 45-amino acid tag attached to the amino-termina l end . As 
shown by immunoblottin g, Sfl) cells infected with baculovirus 
containing either the normal FALDH eDN A or the mutant eDNA 
expressed a 60-kDa FALDH fusion protein (Fig 3). Also present in 
these cells was a smaller imnumoreactive protein that probably 
arises from proteolytic degradation of the 60-kDa protein, beca use 
it was not detected in uninfected cells or in cells infected with 
wild-typ e baculovirus . T he amOlmt of mutant 60-kDa protein was 
slightly less than that of the normal protein . FALDH enzym e 
activity was readily detected in cells infected with virus carrying the 
normal FALDH eDNA. In contrast, enzym e activity in cells 
infected with the mutant FALDH eD NA was severely reduced to 
< 1% of that observed in cells infected w ith the normal FALDH 
eDNA. Control preparations from cells infected with the wild-type 
baculovirus lacking FALDH eDNA showed no 60-kDa FALDH 
pro tein and demonstrate d low enzym e activity levels comparable to 
those o f noninfected cells . T hese results indicate that the C943T 
mutation causes a profound reduction in FALDH en zym e activity. 
C943T Is a Common European SLS Mutation The unex-
pected finding that tw o apparently unrelated SLS probands had the 
sam e point mutation prompted us to screen an additional 17 SLS 
probands from families of European an cestry and three other inbred 
Swedish patients for C943T with the M111l restriction enzyme 
diges tion test. ln total , seven of 19 apparently unrelated pro bands of 
European descent carried the C943T mutation (Table 1). These 
individuals included three Dutch probands, fo ur Swedish p :1 tients 
representing a single kindred, two German probands, and one 
Belgian patient. One Dutch proband and all Swedish patients were 
ho mozygous for C943T, whereas two Dutch probands, two Ger-
man pro bands, and the Belgian patient were heterozygous (Table 
I). Probands from fami lies with the following ethnic origins did not 
can-y the C943T allele: German (four probands), Austrian (one 
proband), Belgian (one proband), French (two pro bands) , Polish 
and Swiss (o ne proband), French/ Irish/German and Lebanese (one 
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Figure 3. C943T mutation destroys catalytic activity of baculovi-
rus-expresscd FALDH. lmmw10staining and FALDH activiry of the 
proteins expressed in Sfl) insect cells infected with baculovirus srraius 
directing the synthesis of the normal FALDH fusion protein or the C943T 
mutant FALDH fusion protein with proline 315 replaced by serine arc 
shown. Approximately 20 JLg of cell protein was loaded onto each lane. 
Proteins were detected with rabbit antiserum raised against rat microsomaJ 
aldehyde dehydrogenase that cross-reacts with human FALDH. La11e 1, 
unin fccted cell s: la11c 2, cells infected with the wild-type AcMPV bacula-
virus lacking FALDH eDNA inserts; la11c 3, cells infected with pAcHLT-
B/FALDHwt virus encoding the wild-rype FALDH fusion protein; ln11e 4, 
ce lls infected with the pAcHLT-B/ FALDH-C943T virus encoding the 
mutant FALDH fusion protein . Note the appearance of a 60-k:Da fusion 
protein (indicated by ->) in ln11es 3 and 4 and a smaller protein that is 
probably a proteolytic product of the FALDH. A weak cross-reacting 
protein of higher molecular weight (indicated by *) is present in the insect 
ce lls. FALDI-1 activiry (n•momoles per min per mg of pmtein) in the cells is 
shown below each lane. 
proband), Germ au /Eng lish/Lithuanian and Hungarian/French/ 
American Indian (one proband) , and German/ Polish/ Siovak a11d 
English/Irish/ American Indian (one proband) . Overall, this C943T 
mutation accounted for nine of the 38 (24%) SLS alleles in 
Eu ropean probands who were thought to be unrelated . Among the 
15 probands ofSwedish, Dutch, German, and Belgian aJJcestry, the 
C943T mutation made up 30% of the SLS alleles, and almost 
one-half (seven of 15) of the probands carried the C943T allele in 
either a homozygous or heterozygous fonn. For these purposes, the 
four Swedish patients were considered to be derived from one 
kindred. The mutation was only present in patients of northern 
Europem1 and Swedish ancestry. 
Haplotype Analysis of SLS Patients with the C943T Muta-
tion The identica] C943T muta tion in seven SLS kindreds from 
northern Europe could have arisen from independent mutational 
events but more likely reflect a common ancestor. T h e latter 
possibility undoubtedly explains the homozygous state of the four 
inbred Swedish patients. Pigg el a/ (1994) demonstrated that there 
is strong allelic association between m arker D 17S805 and the SLS 
locus in their cohort of24 Swedish families. Allele 3, found on o nly 
one of 44 non-SLS chromosom es, was on 37 of 44 SLS chromo-
somes, indicating that there is a founder elfect for SLS in the 
northern part of Sweden. We genotyped nine SLS patients, each 
carrying at least one C943T mutated allele, for D17S805 to 
determine w hether their C943T SLS chromosom es could have 
miginated from the san1e common ancestor as that of the Swedish 
families (Pigg eta/, 1994) . We found that all C943T homozygotes 
were homozygous for D17S805 allele 3 and that each C943T 
heterozygote had one D17S805 allele 3 (Table 1). To ascertain 
whether there is a conunon haplotype associated with the C943T 
mutation , we genotyped the patients for m arkers D17S689 and 
D17S842, which are tightly linked to the SLS locus (Rogers et a/ , 
1995), and a dinucl eotide repeat within the FALDH gene 
(AFMa126yd5). The C943T homozygotes were also homozygous 
for each of these markers identi fyi ng a common haplotype i.n these 
SLS patients (Table 1). Haplotypes could not be unambiguously 
determined in C943T heterozygotes but tl1e genotypes of three 
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Table I. Haplotype A n alysis of SLS P atien ts carrying the C943T M ulta tion" 
Marker Genotype" 
Proband Ethnicity D17S689 D I7S805 AFMa126yd5 C<J43T D17S842 
Dutch 3 2 T 3 
3 2 T 3 
2A' Swedish 3 2 T 3 
3 2 T 3 
2D Swedish 3 2 T 3 
3 2 T 3 
2C Swedish 3 2 T 3 
3 2 T 3 
Dutch 5 3 2 T 3 
4 2 c 3 
4 Dutch 5 3 2 T 3 
6 2 c 3 
5 German 3 2 T 3 
4 G 2 c 3 
6 German 1 2 T 3 
6 6 2 c 
7 Belgian 3 2 T 3 
4 3 c 
Cotnn1on 
haplotype 1'' 3'' ?! T }' 
•' Haplotyp cs arc boxed w ith a soli d lin e: in ferred haplotypcs arc within <1 screened box . 
" Mnrkcr order w ere ded uced from Gerken et nl (1995) , W hitchc01d 1nstitutc yeast art ifi cia l ch romosome dal'.1 , ;md R ogers and Compto n (u npublished d:H":1) . 
1 Swed ish pntients arc in bred (Pi gg ct nl, 1994) and nrc considered to represent o ne kin dred. 
11 A 13(J-bp allele, all elic frequency unknow n. 
' Alle lic frequ ency (1.1)5 (Genome Database). 
I All elic frequen cy O.M (data not shown). 
·' All eli c frcq ucnty 0. 71 (Geno me Database). 
patien ts of Germa n and Belg ian descen t wet·e consisten t with the 
presence of the disease haplotype on one chro mosome . T he two 
D utch C943T heterozygotes also shared the alleles of the di sease 
haplotype except fo t· the most dista n t D l 7S689 locus. T he presence 
of a common haplotype in th ese patien ts wo uld be expected if SLS 
in these popu lations is due to a comm on ancestor in whom the 
C943T m utation origina ll y occurred. O ur resul ts strongly suggest 
that the C943T m utation is the preva len t SLS m utation in the 
Swedish popu lation and that the associated haplotype is also 
segregating in the northern European popul ati on . 
DISCUSS IO N 
T he C943T mutation , w hich replaces pro line 315 w ith serin e, 
resu.l ts in a profound loss of FALDH activity . T he m uta n t enzyme 
expressed in iJlsect cells appea red to be relatively stable compared 
to the no rm al FALDH, as judged by steady-state protein leve ls 
de tected by im m unoblotting. Nevertheless, d1is m utant FALDH 
had less than l % of the nom1al enzyme activity . Proline 31 5 is a 
h ighl y conserved amin o acid within d1e aldehyde dehydrogenase 
family and conta ins a proline-threonin e motif tha t is iJJ va ri an t in 16 
other a.l dehyde dehydrogenase enzymes ranging from microorgan-
isms to hum ans (Hempel cl a/, 1993). In terestingly, proli ne 315 is 
also altered by a deletion/ in sertion mu t;1tion in another SLS patien t 
(De La urenzi et nl, 1996) and mu st, the re fore, play a crttcial role in 
protein structure and/ or catalytic efficiency of FALDH. 
O ur stud ies indicate that the C943T mu tation is a comm on ca use 
of SLS in fa milies fi·o m no rthe rn Europe. T he mu tation was 
o bserved in seven of19 SLS fam ilies fro m Europe , bu t it has not ye t 
been fo und in SLS fa milies o f other ethnic orig in (Rizzo, un pu b-
l.i shed observa tions) . Within the 15 no rthern European fa milies 
ari sing from Sweden , the N etherl ands, Germ an y, and Belgium , d1e 
C943T mutation acco un ted fo r nine of 30 SLS allc le.s, and almost 
one-h alf of the probands carried the mu tation in a heterozygous o r 
homozygous form . T he findin g of a shar ed haplotype supports the 
hypothesis that the f<un iJies segrega tin g C943T all e l.e are genetica ll y 
related . T he homozygous D utch patien t has the iden tica l haplotype 
of the inbred Swedish patients and , except fo r the more distal 
marker D 17S689, the beterozygotes fro m the Nethe rlands, Ger-
many, an d Belgi um share the sam e all ele as the C943T homozy-
gotes . T his findin g, togethe r with the geographic clu sterin g of the 
C943T m uta tion, is most consistent w ith a co mmon ancestor and 
not eas ily explained by independent m utational events. 
T he C943T mu tation probabl y represen ts the maj or SLS allel e 
am ong Swedish patien ts . . Pedigree studies (Sjogren an d La rsso n, 
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1957; Jagell et al, 1981) and haplotype analysis (Pigg ct a/, 1994) 
indicate that most Swedish SLS patients are genetically related. By 
using the Nlnll res triction enzyme diges tion screening test, we 
found that all four Swedish SLS patients were homozygous for 
C943T, and DNA sequen cing of the entire coding region of one 
Swedish patient fu.iled to reveal any other mutations. T he existence 
of other possible SLS all eles in this population should be readily 
evident by M 11ll screening of additional Swedish patients , particu-
larly those who cannot be genetically traced to known inbred 
fa m.ili es. 
Genotype analysis demonstrates that there is a founder effect for 
SLS in the northern part of Sweden (Pigg et al, 1994) . Genetic 
studies of the Swedish patients in the coun ty of Vasterbotten have 
led to the hypothesis that the Swedish SLS gene either arose in a 
found er around the 13th century or was brought into this isolated 
geographic region dming a migration of settlers from southern 
Sweden in tl1e 14th century (IseUus and Jagell , 1989). If canied to 
northern Sweden by migration, the Swedish SLS gene is thought to 
have first arisen long before the 14th century (IseUus and Jagell, 
1989). Our results suggest that the C943T allele might have spread 
tlu·oughout northern Europe during a population migration that 
occurred in tlus area prior to the 14th century. In particular, the 
Vikings estabUshed settlem ents in va1ious locations in northern 
Europe during the 9th and 10th centuries Qones, 1985), including 
regions that now are Germany, the Netherlands, and Belgium. We 
speculate that migration of one or more C943T carriers into northern 
Europe occurred during tlus peLiod. D eternun ation of the allele 
fi:equencies of C943T and other rare genes in populations currently 
living in the regions of nortl1em Ew-ope where Viking settlements are 
known to have been established may be infonnative . 
It should now be possible to perform DNA-based diagnosis of 
SLS by screening for the C943T mu ta tion , with the N!nll restriction 
digestion test described herein , rathe r than relying on enzymatic 
methods that require cultured skin fibrobl asts or leukocytes (Rizzo, 
1993) . T he M111I digestion test is simple and can be performed with 
DNA derived f:i-0111 a non-invasive method such as buccal brushings 
(Richards el a/, 1993) . Among GlllliUes segregating the C943T 
allele, this test will pennit DNA-based carrier detection and 
prenata l diagnosis . Alterna tively, the use of allele-specific oligonu-
cleotides (Saiki et a/, 1986) may be more appropriate for large scale 
population-based scree11ing ofC943T. Enzymatic testing, however, 
will remain the definitive m eans to diagnose SLS patients who do 
not carry the C943T mutation or who are not fi·om northem 
Europe and Sweden. 
This research was mpp011ed i11 pm1 by grn11ts ji·om the A.D. J¥ illinms Fo1111dntio11 
of Vit;giltin CoiiiiiiOII II/en lth U11i11ersity n11d Teleto 11 (Grn 11t E413) . 
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